Furthermore, in patients with Alzheimer’s disease, lower abundances of Roseburia hominis were associated with both higher amyloid and lower phosphorylated-tau levels (Verhaar et al., 2021), which supports a potential role along the gut–brain axis. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.